Cases 11 - 20 of 36
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Taro Pharmaceutical Industries Ltd. et al v. Encube Ethicals Pvt. Ltd.
as 1:2021cv01614
Counter Defendant:
Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals North America, Inc. and Taro Pharmaceuticals U.S.A., Inc.
Defendant:
Encube Ethicals Pvt. Ltd.
Cause Of Action: 35 U.S.C. § 1
Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al
as 1:2021cv01000
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH US, LLC et al v. TARO PHARMACEUTICALS U.S.A., INC. et al
as 3:2020cv02747
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH US, LLC and others
Defendant:
TARO PHARMACEUTICALS U.S.A., INC., TARO PHARMACEUTICAL INDUSTRIES LTD. and TARO PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
LEO Pharma A/S et al v. Taro Pharmaceuticals U.S.A. et al
as 1:2019cv00221
Defendant:
Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A.
Plaintiff:
LEO Pharma A/S, Foamix Pharmaceuticals Ltd. and LEO Pharma Inc.
Cause Of Action: 35 U.S.C. § 271
TARO PHARMACEUTICAL INDUSTRIES LTD. et al v. NOVITIUM PHARMA, LLC
as 3:2019cv01028
Plaintiff:
TARO PHARMACEUTICALS U.S.A., INC., TARO PHARMACEUTICAL INDUSTRIES LTD. and TARO PHARMACEUTICALS NORTH AMERICA, INC.
Defendant:
NOVITIUM PHARMA, LLC
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al
as 1:2018cv01673
Defendant:
Cipla Limited, Perrigo Company plc, Taro Pharmaceuticals U.S.A., Inc. and others
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. TARO PHARMACEUTICALS U.S.A., INC. et al
as 3:2018cv15060
Defendant:
TARO PHARMACEUTICAL INDUSTRIES LTD., TARO PHARMACEUTICALS U.S.A., INC. and TARO PHARMACEUTICALS INC.
Plaintiff:
KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Cause Of Action: 35 U.S.C. § 271
Delcor Asset Corporation et al v. Taro Pharmaceutical Industries, Ltd. et al
as 1:2017cv00970
Plaintiff:
Delcor Asset Corporation and Mylan Pharmaceuticals Inc.
Defendant:
Taro Pharmaceutical Industries, Ltd. , Taro Pharmaceuticals U.S.A., Inc. and Stiefel West Coast, LLC
Cause Of Action: 35 U.S.C. § 145
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
